Literature DB >> 14607739

The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.

Shi-Bin Xie1, Ji-Lu Yao, Shu-Sen Zheng, Chun-Lan Yao, Rong-Qin Zheng.   

Abstract

OBJECTIVE: To study the relationship between the serum levels of hyaluronic acid (HA), procollagen type III (PCIII), collagen type IV (CIV) and the histological degree of hepatic fibrosis evaluated by image analysis, and the clinical significance of serum HA, PCIII, CIV in the diagnosis of hepatic fibrosis in patients with chronic viral hepatitis.
METHODS: The concentrations of serum HA, PCIII, CIV in 151 patients with chronic viral hepatitis were measured by radioimmunoassay. Liver biopsies were performed in all the patients. Histological sections of 4 microm thickness were stained with Masson's trichrome for fibrosis assessment. Morphometric quantitative measurements for hepatic fibrosis assessment in the 4 microm sections were performed using a fully automated image analysis system. Serum levels of HA, PCIII, and CIV were analyzed at different stages of liver pathology and compared with the morphometric quantitative measurements of hepatic fibrosis.
RESULTS: The serum levels of HA, PCIII, CIV all elevated gradually with the progression of the disease, and all reached the highest in patients with liver cirrhosis. There was a significant difference in the levels of these 3 components between liver cirrhosis group and the other groups (P<0.05). They all increased steadily with the histological stages of hepatic fibrosis, and reached the highest levels in stage IV. The serum levels of HA, PCIII, CIV were all positively correlated with the histological stages of liver sections and the morphometric measurement (P<0.001). The coefficients with stages were 0.694, 0.493, 0.552 (P<0.001), respectively and with surface density of total collagen on liver biopsy sections by image analysis were 0.715, 0.595, 0.573 (P<0.001), respectively.
CONCLUSION: The serum levels of HA, PCIII, CIV were in consistent with the degree of hepatic fibrosis, and the determination of these marks is valuable for detecting hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14607739

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  7 in total

1.  Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.

Authors:  Memy H Hassan; Mohamed M Ghobara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-31       Impact factor: 3.000

2.  Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study.

Authors:  Yi-Min Mao; Min-De Zeng; Lun-Gen Lu; Mo-Bin Wan; Cheng-Zhong Li; Cheng-Wei Chen; Qing-Chuen Fu; Ji-Yao Wang; Wei-Min She; Xiong Cai; Jun Ye; Xia-Qiu Zhou; Hui Wang; Shan-Ming Wu; Mei-Fang Tang; Jin-Shui Zhu; Wei-Xiong Chen; Hui-Quan Zhang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

3.  Evaluation of changes of serum hepatitis B surface antigen from a different perspective.

Authors:  Ze-Qian Wu; Lei Tan; Ting Liu; Zhi-Liang Gao; Wei-Min Ke
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

4.  Development of a novel in vivo corneal fibrosis model in the dog.

Authors:  K M Gronkiewicz; E A Giuliano; K Kuroki; F Bunyak; A Sharma; L B C Teixeira; C W Hamm; R R Mohan
Journal:  Exp Eye Res       Date:  2015-10-09       Impact factor: 3.467

5.  Serum Liver Fibrosis Markers in the Prognosis of Liver Cirrhosis: A Prospective Observational Study.

Authors:  Xingshun Qi; Xu Liu; Yongguo Zhang; Yue Hou; Linan Ren; Chunyan Wu; Jiang Chen; Chunlian Xia; Jiajun Zhao; Di Wang; Yanlin Zhang; Xia Zhang; Hao Lin; Hezhi Wang; Jinling Wang; Zhongmin Cui; Xueyan Li; Han Deng; Feifei Hou; Ying Peng; Xueying Wang; Xiaodong Shao; Hongyu Li; Xiaozhong Guo
Journal:  Med Sci Monit       Date:  2016-08-02

6.  Hepatitis C virus load in parenchyma cells correlates with hepatic injury in infected patients.

Authors:  Zhen Xu; Ji-Zong Lin; Guo-Li Lin; Fang-Fang Wei; Jing Liu; Zhi-Xin Zhao; Ying Zhang; Wei-Ming Ke; Xiao-Hong Zhang
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

7.  The clinical value of serum hepatic parenchyma cell volume-normalized hepatitis B surface antigen levels in hepatitis B e antigen -positive and -negative chronic hepatitis B patients.

Authors:  Lei Tan; Shi-Lei Xu; Zhi-Shuo Mo; Jian-Rong Liu; Wei-Qiang Gan; Jie-Huan Chen; Zhi-Liang Gao; Ze-Qian Wu
Journal:  Ann Transl Med       Date:  2021-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.